Nation's Restaurant News
Home > Market Monitor

Market Monitor

NRN Stock Indexes
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
BioMarin Pharmaceuticals, Inc. (NQ: BMRN)
64.01 USD  -0.49 (-0.76%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about BioMarin Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
BioMarin Pharmaceutical Has Returned 28.9% Since SmarTrend Recommendation (BMRN)
March 12, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceutical Earnings Review: 18 Days after Announcement Shares Up 15.4% (BMRN)
March 11, 2013
from Comtex SmarTrend® News Briefs
Watch for Continued Gains in Shares of BioMarin Pharmaceutical (BMRN)
March 08, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceutical: 52-Week High Recently Eclipsed (BMRN)
March 07, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceutical Has Returned 16.6% Since SmarTrend Recommendation (BMRN)
February 26, 2013
from Comtex SmarTrend® News Briefs
Lightning Round: Vonage, Bank of America, Molycorp and More
February 22, 2013
You say the name of a stock and Cramer tells you whether to buy, buy, buy or sell, sell, sell! Read More
category BioMarin Pharmaceutical Inc , Frontier Communications Corp/ , Economics , and 21 more.
from CNBC.com News
BioMarin (BMRN) Licenses Factor VIII for Hemophilia A from UCL
February 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8122087 for the full story. Read More
from StreetInsider.com News Articles
BioMarin Pharmaceuticals, Inc. (BMRN) Posts Q4 GAAP Loss of 43c/Share; Guides FY13
February 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8122078 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 02/21: Wal-mart (WMT), AIG (AIG), H-P (HPQ), Chesapeake (CHK), Safeway (SWY) Report
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8117866 for the full story. Read More
from StreetInsider.com News Articles
BioMarin Reports Statistically Significant Changes in Kuvan Responding PKU Patients
February 19, 2013
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today results from the PKU-016 ASCEND study, the largest randomized controlled trial evaluating neuropsychiatric outcomes in phenylketonuria (PKU)... Read More
category Benzinga , BMRN , News , and 1 more.
from Latest Articles from Benzinga.com
Loeb's Third Point New Stake in (DG) (HLF) (MS) (NWSA) (TSO); Cuts (AIG), Liquidates (AAPL)
February 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8104105 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Canaccord Genuity Raises PT to $71 on BioMarin Pharmaceutical on Upcoming Catalysts
February 12, 2013
Canaccord Genuity maintained BioMarin Pharmaceutical (NASDAQ: BMRN ) with a Buy rating and raised the price target from $56.00 to $71.00. Canaccord Genuity commented, "Given that we view 2013 as a key... Read More
category Canaccord Genuity , Benzinga , BMRN , and 4 more.
from Latest Articles from Benzinga.com
Catyalyst (CPRX) Updates on Pipeline; Sees Filling NDA for Firdapse After Q115
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8077223 for the full story. Read More
from StreetInsider.com News Articles
Are Drugs for Ultra-Rare Diseases the Future of Biotech? Francois Nader of NPS Weighs In
February 05, 2013
Over the last ten years, the global pharmaceutical industry has undergone dramatic changes. In the 1990s, big drug companies made hundreds of billions of dollars selling slightly improved versions of... Read More
category NYSE:SNY , NYSE:PFE , NASDAQ:NPSP , and 2 more.
from Forbes Real Time
Uptrend Call Working As BioMarin Pharmaceutical Stock Rises 16.7% (BMRN)
February 05, 2013
from Comtex SmarTrend® News Briefs
BioMarin seeks to test enzyme-replacement therapy in Batten Disease patients
January 22, 2013
BioMarin Pharmaceutical Inc. doesn't back down from a tough rare disease. The Novato company (NASDAQ: BMRN), which made its name with enzyme-replacement therapies that tackle virtually unpronounceable... Read More
from National Business News - Local Business News | bizjournals
UPDATE: Stifel Nicolaus Upgrades BioMarin Pharmaceutical on Catalysts
January 22, 2013
Stifel Nicolaus upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) from Hold to Buy and announced a $67.00 price target. Stifel Nicolaus commented, "We believe anticipation around a YE13 GALNS... Read More
category Benzinga , US09061G1013 , Stifel Nicolaus , and 5 more.
from Latest Articles from Benzinga.com
Watch for Continued Gains in Shares of BioMarin Pharmaceutical (BMRN)
January 22, 2013
from Comtex SmarTrend® News Briefs
Upgrade Alert for BioMarin Pharmaceutical (BMRN)
January 22, 2013
from Comtex SmarTrend® News Briefs
Upgrade Alert for BioMarin Pharmaceutical (BMRN)
January 22, 2013
from Comtex SmarTrend® News Briefs
Stifel Nicolaus Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
January 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8021259 for the full story. Read More
from StreetInsider.com News Articles
Drug Pipelines Begin to Fill For Big Pharma
January 13, 2013
The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap. Read More
category BioMarin Pharmaceutical Inc , ONYX Pharmaceuticals Inc , Eli Lilly and Company , and 6 more.
from CNBC.com News
Pipeline Winners: Should You Bank on Biotech?
January 11, 2013
Jim Cramer's researcher Nicole Urken reviews the potential biotech pipeline winners there were highlighted this week on Mad Money Read More
category BioMarin Pharmaceutical Inc , Apple Inc , Eli Lilly and Company , and 12 more.
from CNBC.com News
UPDATE 1-BioMarin won't sell itself for 25-30 pct premium-CEO
January 08, 2013
SAN FRANCISCO Jan 8 (Reuters) - BioMarin Pharmaceutical Inc , which makes high-priced drugs used to treat rare diseases, would not consider a buy-out offer for even a 25-30 percent premium, according... Read More
category companyNews
from Reuters: Company News
UPDATE: BioMarin (BMRN) Won't Sell Even for 25% - 30% Premium
January 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7994999 for the full story. Read More
from StreetInsider.com News Articles
BioMarin won't sell itself even for 25-30 pct premium-CEO
January 08, 2013
SAN FRANCISCO Jan 8 (Reuters) - BioMarin Pharmaceutical Inc , which makes high-priced drugs used to treat rare diseases, has been approached by potential acquirers but would not sell itself for even a... Read More
category companyNews
from Reuters: Company News
3 Top Health Care Plays: Barbara Ryan
January 07, 2013
Strong fundamentals and dominant market positions make three biotech/pharma names stand out, analyst Barbara Ryan says. Read More
category Biogen Idec Inc , tvcodes/TVFMHRWEBEX , BioMarin Pharmaceutical Inc , and 4 more.
from CNBC.com News
Janney Montgomery Scott Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
January 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7978547 for the full story. Read More
from StreetInsider.com News Articles
Celgene Among Healthcare's Biggest Movers on January 2, 2013
January 02, 2013
The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed 1.9%. The healthcare sector is the category of stocks relating to medical and healthc... Read More
from Investopedia Advisor Commentary
Highlights on Options Activity for BioMarin Pharmaceutical
December 11, 2012
NEW YORK (AVAFIN) -- A record number of BioMarin Pharmaceutical call contracts were traded ... Read More
from AVAFIN
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
NRN.com
Penton Restaurant Group
Copyright © 2012 Penton Media, Inc.